Partner Groups & Centres

MRC CoRE in Therapeutic Genomics

The MRC CoRE in Therapeutic Genomics is a UK research centre with a mission to revolutionise the treatment of genetic diseases through therapeutic genomics. Its vision is to create a new generation of affordable, personalised medicines that can be rapidly adapted to treat a wide range of rare and common conditions.

MRC/BHF CoRE in Advanced Cardiac Therapies (REACT)

The MRC/BHF CoRE in Advanced Cardiac Therapies aims to develop the first regenerative gene therapies for heart failure. Its vision is to reawaken the heart’s natural repair mechanisms using nucleic acid technologies, with the goal of delivering globally accessible, transformative treatments for the millions affected by heart disease.

Oxford Vaccine Group (OVG)

The Oxford Vaccine Group (OVG) is a world-leading vaccine research group with 30 years of pioneering work in vaccine development. Its mission is to improve global health through immunisation by advancing vaccine discovery, development, clinical trials, and policy.

Website Link  

Oxford-Harrington Rare Disease Centre (OHC)

The Oxford-Harrington Rare Disease Centre (OHC) is a unique transatlantic partnership with a mission to deliver new treatments for the approximately 500 million people affected by rare diseases worldwide. Its vision is to advance 40 drugs into clinical trials by 2034.

Website Link  

Pandemic Sciences Institute (PSI)

The Pandemic Sciences Institute is a global Oxford-led initiative dedicated to preventing future pandemics through science, innovation, and collaboration. It works with international partners to accelerate the development of vaccines and to ensure equitable access to pandemic solutions worldwide.

Website Link  

Translational Research Immunology Group (TRIG)

The Translational Research Immunology Group (TRIG) is a multidisciplinary Oxford-based team advancing immunological research in transplantation, cancer, and autoimmunity. With over 35 years of impact, TRIG focuses on translating discoveries in immune regulation and tolerance into cellular therapies and clinical trials.

Website Link  

TransNAT

TransNAT is a UK-based consortium advancing nucleic acid therapies (NATs) to treat genetic diseases by improving safe and targeted delivery of genetic medicines. It unites leading academic and industry partners to overcome delivery challenges and accelerate clinical impact for rare and common genetic disorders.

Website Link